Research
Lack of access to medicine is a major driver of drug resistance. How can pharma take action?
27 October 2022
Suzi van Es to join panel discussion on how investors can address AMR
The Access to Medicine Foundation is set to attend the Responsible Investor's 16th annual conference, RI Europe 2023, hosted in London. As part of the event, the Foundation’s Investor Engagement Manager, Suzi Van Es, will join a panel discussion on the pressing issue of antibiotic resistance and the critical role of investors in addressing this systemic societal risk.
Date
14 June 2023
Date
14 June 2023
Location
London, United Kingdom
Format
In-person
Responsible Investor (RI) Europe 2023 is a two-day conference that convenes leaders in sustainable investing to discuss the latest trends and strategies for creating positive social and environmental impact.
The Access to Medicine Foundation’s Suzi van Es, Investment Engagement Manager, will be attending the conference, where she will join a panel titled 'Antibiotic resistance: What role do investors have in addressing this systemic societal risk?’.
The panel discussion, moderated by Georgie Stewart, CEO of Tumelo, will focus on:
the potential harm from mass antimicrobial resistance (AMR);
tools and methodologies investors can use to assess AMR risks;
the practical role of investors in addressing AMR; and
challenges in engaging with companies on systemic risks.
Suzi will draw on the Foundation's work, particularly the Investor Action on AMR Progress Report, to discuss how investors can tangibly support global efforts to curb rising AMR and why it is essential that more investors work to formally assess and integrate AMR risks through a holistic and multi-sectoral “One Health” approach.
Bram Wagner, Investment Engagement Officer at the Foundation, will also attend the conference to discuss the Foundation's work on AMR.